Integrated BioPharma Financial Overview
Integrated BioPharma's market cap is currently $9.44M. The company's EPS TTM is $0.004; its P/E ratio is 14.34; Integrated BioPharma is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
